Xcout Intel
Space LiinTech
Space LiinTech is a space biopharma company headquartered in Daejeon, South Korea, that develops AI-enabled microgravity platforms for pharmaceutical research.
Subscribe to see Space LiinTech’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Space LiinTech at a glance
Space LiinTech is a space biotechnology company headquartered in South Korea. Its most recent funding round, Pre-Series A, raised $4M in May 2024. Xcout tracks 5 named people at Space LiinTech, including Jung-uk Shim (Director & CTO).
Space LiinTech leadership
- Jung-uk ShimDirector & CTO
- Byeong Kon KimEVP Head of Space Platform Development Division
- Byeongho KimSVP Head of Space Medicine Business Division
- Hunjae JeongDirector Head of Business Support, HR Team Lead, and Finance & Accounting Team Lead
- Younghoon LeeDirector Head of Space Medicine Research Institute
Space LiinTech funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Series A | $4M | 16 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Space LiinTech competitors
A few of Space LiinTech's closest competitors — see the full list of competitors and alternatives →
Spark Biopharma is headquartered in Seoul, South Korea, and focuses on discovering and providing small-molecule therapeutics using phenotypic discovery platforms to improve human health.
LigaChem Biosciences is a clinical-stage biopharmaceutical company headquartered in Daejeon, South Korea. The company specializes in the discovery and development of novel therapeutics utilizing proprietary technology platforms such as antibody-drug conjugates. With decades of dedicated drug development experience, it drives global healthcare innovation through open collaboration.
IntoCell is a South Korean biotechnology company founded in 2015 and headquartered in Daejeon, specializing in drug-conjugate and related pharmaceutical technologies.
Y-Biologics is a South Korea-based research and development biotechnology company headquartered in Daejeon. The firm focuses on developing novel antibody-based therapeutics using its proprietary platform technologies and pipelines.
Exobiosphere is a privately held space-biotech company headquartered in Esch-sur-Alzette, Luxembourg. Founded in 2024, its mission is to extend and improve life on Earth and in space by utilizing microgravity as a new dimension for biology to accelerate drug research.
1STBIO is a South Korea-based biotherapeutics company utilizing a proprietary AI-based drug discovery platform and genomic-based target discovery to enhance R&D efficiency. The firm is dedicated to discovering and developing novel therapeutics for areas of significant unmet medical need with a small team of 29 employees.
Get Space LiinTech's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Space LiinTech in Xcout Intel
- 5 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access